Childhood eczema — clinically known as atopic dermatitis — affects roughly 10-15% of American children, making it one of the most common chronic skin conditions in pediatrics. It usually starts in the first year of life, follows a relapsing-remitting course through childhood, and resolves or improves substantially in many children by adolescence. Eczema is also the leading edge of the “atopic march,” the developmental sequence in which infants with severe early eczema have higher risk of food allergy, asthma, and allergic rhinitis later. Treatment has improved considerably in the last decade with new topical and biologic options that go well beyond the older steroid-and-moisturizer model. This guide is educational and does not replace advice from your child’s clinician.
What Eczema Is
Atopic dermatitis is a chronic, inflammatory skin disease driven by a combination of skin barrier dysfunction (often from filaggrin gene mutations), immune dysregulation toward type 2 inflammation, and environmental triggers. The result is dry, itchy, inflamed skin that flares and remits, often along characteristic age-specific patterns: cheeks and scalp in infants, flexural creases (elbows, knees, neck) in older children, and similar flexural plus hand involvement in adolescents and adults.
The hallmark symptom is itch — sometimes intense enough to disrupt sleep and concentration. Scratching damages the skin further, creating an itch-scratch cycle that worsens inflammation and risks bacterial superinfection, especially with Staphylococcus aureus. Per the National Eczema Association and Cleveland Clinic, severity ranges from mild occasional dryness to severe, debilitating disease covering most of the body. The American Academy of Dermatology notes that when a child develops eczema it is usually atopic dermatitis, and that it often begins by 5 years of age.
Causes and Triggers
The underlying drivers are genetic. Children with a parent or sibling with eczema, asthma, or allergic rhinitis are at significantly higher risk. Common triggers that worsen flares include: dry climate and low humidity, hot water bathing, harsh soaps and detergents, fragrances in skin care and laundry products, wool and synthetic fabrics, sweating and overheating, stress, and viral upper respiratory infections. Environmental allergens like dust mites, pet dander, and pollen can drive flares in some children. Triggers are highly individual, so what worsens one child’s eczema may have no effect on another’s.
Food allergy plays a smaller role than parents often assume. About one-third of children with moderate-to-severe eczema have at least one IgE-mediated food allergy, but identifying and removing food triggers rarely cures eczema, and elimination diets done without allergist supervision often cause more harm than benefit, including nutritional gaps and, paradoxically, new food allergies after prolonged avoidance. Any dietary change in a child with eczema should be guided by a pediatrician or allergist.
Diagnosis
Eczema is diagnosed clinically based on history and the appearance and distribution of skin findings. Pediatricians and dermatologists use the Hanifin-Rajka criteria or simpler practical features: pruritus (itch), typical age-appropriate distribution, chronic relapsing course, and personal or family history of atopy. Biopsy is rarely needed.
Allergy testing is reserved for cases with suspected specific IgE-mediated triggers — typically severe, refractory eczema in infants where food allergy is suspected, or older children with environmental triggers. Routine broad food allergy panels are not recommended and lead to many false positives, which can trigger unnecessary and harmful food avoidance.
Treatment: The Modern Stepwise Approach
Current AAD and American Academy of Pediatrics guidance emphasizes a stepwise approach. Step one is daily moisturization with thick fragrance-free emollients — petrolatum-based ointments and creams generally outperform lotions. Apply liberally at least twice daily, especially within 3 minutes after bathing (“soak and seal”). Daily lukewarm baths with mild fragrance-free cleansers, followed immediately by moisturizer, are generally preferred over infrequent bathing for most patients. Consistent moisturizing is the single most important habit and reduces how often flares need prescription treatment.
Step two adds topical anti-inflammatories during flares. Low-potency topical corticosteroids (hydrocortisone 1-2.5%) for face and skin folds, mid-potency (triamcinolone, mometasone) for body. Used appropriately and as directed by a clinician, topical steroids are safe and effective — the common fear of “steroid harm” leads many families to under-treat, which prolongs flares. The key is matching potency to body site and using them for the recommended duration rather than avoiding them or, conversely, using strong steroids on the face long-term. Topical calcineurin inhibitors (tacrolimus, pimecrolimus) and the non-steroid option crisaborole can be used for sensitive areas or as steroid-sparing maintenance. Newer non-steroid topicals — ruxolitinib cream, roflumilast cream, and tapinarof cream — have expanded the options in recent years; age indications differ by product and change over time, so confirm current labeling and suitability with your child’s prescriber.
Step three is for moderate-to-severe disease that does not respond to topicals. Systemic options now include dupilumab (Dupixent), an injectable biologic targeting the IL-4/IL-13 pathway that is FDA-approved down to 6 months of age. Additional biologics targeting type 2 inflammation have been approved for adolescents and adults in recent years. Oral JAK inhibitors (upadacitinib, abrocitinib) are options for older children and adolescents but carry boxed safety warnings and require monitoring. Phototherapy, methotrexate, cyclosporine, and azathioprine remain options in selected cases. All systemic therapy is prescriber-directed and reserved for disease that topicals cannot control.
Bleach Baths and Infection Control
Children with eczema are colonized with Staphylococcus aureus at much higher rates than the general population. Frequent superinfection with weeping, crusted, or honey-colored lesions warrants topical or oral antibiotics prescribed by a clinician. Dilute bleach baths (about 1/4 to 1/2 cup of regular household bleach in a full bathtub of water, twice weekly, soaked for 5-10 minutes) may reduce bacterial colonization and flare frequency in moderate-to-severe disease per AAD guidance, though the benefit is modest and the routine should be confirmed with your pediatrician before starting, especially for infants.
Eczema herpeticum — disseminated herpes simplex infection on eczematous skin — is a dermatologic emergency. It presents as punched-out vesicles that can become widespread, often with fever and feeling unwell, and is treated with systemic acyclovir or valacyclovir. It needs urgent medical attention.
The Atopic March
Severe early eczema is associated with substantially increased risk of subsequent food allergy, asthma, and allergic rhinitis. The 2017 NIAID peanut allergy prevention guidelines specifically recommend introducing peanut by 4-6 months in high-risk infants — those with severe eczema, egg allergy, or both — to substantially reduce peanut allergy risk; timing and approach for an individual infant should be discussed with the pediatrician. Aggressive eczema control in infancy may modify the atopic march, though evidence on long-term prevention of asthma is mixed and skin-barrier interventions have not reliably prevented food allergy in trials.
When to See a Pediatrician or Dermatologist
Routine eczema is usually managed by pediatricians. Refer to a pediatric dermatologist for: eczema not controlled with mid-potency topical steroids and consistent moisturization, suspected allergic contact dermatitis, frequent skin infections, eczema affecting sleep or quality of life, suspected eczema herpeticum, and consideration of systemic therapy or biologics like dupilumab. Allergists are appropriate when food allergy is strongly suspected or when environmental triggers are unclear. Do not hesitate to ask for referral if a child’s eczema is poorly controlled — earlier specialist input often shortens the path to relief.
When to seek emergency care: Call 911 or go to the emergency room if your child develops widespread punched-out vesicular lesions (suspected eczema herpeticum), high fever with rapidly spreading red painful skin (suspected severe bacterial infection), facial swelling with breathing difficulty (anaphylaxis), or signs of sepsis such as lethargy, mottled skin, or extremely fast breathing. Most eczema flares are not emergencies, but secondary infections occasionally are.
Daily Practical Care
Practical day-to-day care that pediatric dermatologists recommend: lukewarm short baths, fragrance-free non-soap cleansers, immediate moisturization with thick ointment after bathing, soft cotton clothing, fragrance-free laundry detergent, double-rinsing laundry, keeping nails trimmed short (and cotton mittens for infants who scratch in their sleep), a cool sleeping environment, and identifying personal triggers. Hard water has been associated with eczema in some studies, though dedicated water softeners have not consistently shown benefit in trials. Wet-wrap therapy, applied under clinician guidance during severe flares, can also help calm stubborn inflammation.
Frequently Asked Questions
Will my child outgrow eczema?
Many children improve substantially by adolescence. Roughly half outgrow it largely or completely, and another portion experience milder, more localized disease into adulthood. Children with severe early eczema, family history of atopy, and early food allergy are more likely to have persistent disease.
Is eczema contagious?
No. Eczema itself is not contagious. Bacterial superinfection (impetigo on eczema) and eczema herpeticum can be contagious, so cover infected lesions until treated and check with your clinician.
Should I avoid bathing my child to keep their skin from drying out?
The current evidence supports daily lukewarm short baths with mild cleansers followed immediately by thick moisturizer. The “soak and seal” technique hydrates the skin barrier better than infrequent bathing.
Are topical steroids safe for my child?
When prescribed and used as directed — the right potency for the body site and for the recommended duration — topical corticosteroids are considered safe and effective for eczema flares. Problems usually come from misuse, such as using potent steroids on the face long-term, not from appropriate use. Undertreating out of “steroid fear” tends to prolong flares. Ask your clinician how and where to apply each product you are given.
Is dupilumab safe for young children?
Dupilumab is FDA-approved down to 6 months of age for moderate-to-severe atopic dermatitis. It targets the IL-4 and IL-13 pathways and has shown a strong safety profile in clinical trials, with conjunctivitis being among the most common side effects. It is generally reserved for moderate-to-severe disease not controlled with topical therapy and is prescribed and monitored by a specialist.
What are the newer non-steroid creams for eczema?
Beyond calcineurin inhibitors and crisaborole, several newer non-steroid topicals have been approved in recent years, including ruxolitinib cream, roflumilast cream, and tapinarof cream. Approved ages and appropriate uses differ by product and can change, so ask your child’s dermatologist which options fit your child’s age and eczema severity, and verify current labeling.
Quick summary: Childhood eczema (atopic dermatitis) is a common, manageable chronic skin condition. Daily moisturizing and gentle bathing form the foundation; topical corticosteroids and non-steroid topicals (calcineurin inhibitors, crisaborole, and newer options like ruxolitinib, roflumilast, and tapinarof) treat flares as directed by a clinician; and prescriber-directed systemic options such as dupilumab exist for moderate-to-severe disease. Use topical steroids as prescribed rather than fearing appropriate use, see a pediatrician or dermatologist for poor control or frequent infections, and seek urgent care for suspected eczema herpeticum. Drug approvals and age cutoffs change — verify current guidance with your clinician. This article is educational and is not a substitute for personalized medical advice.
The Bottom Line on Childhood Eczema
Childhood eczema is a chronic, manageable condition with well-established treatments and increasingly effective options for severe disease. Daily moisturization, gentle bathing, and appropriate topical anti-inflammatories during flares control most cases. Severe disease deserves dermatology referral early — both for skin control and to manage the atopic march toward asthma and food allergies. Regular well-child visits are a good place to track flare frequency, growth (eczema severity sometimes affects sleep and growth), and overall pediatric care within the larger context of chronic childhood conditions.
Sources
- American Academy of Dermatology (AAD) — Atopic dermatitis in children, and Guidelines of care for the management of atopic dermatitis
- American Academy of Pediatrics — HealthyChildren.org, eczema in children
- National Eczema Association
- Cleveland Clinic — Eczema
- NIAID — Addendum guidelines for the prevention of peanut allergy (2017)